A comprehensive review of the first half of PMP processes—scope planning and management—using topic-specific ...
Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...
APPN] and PSI CRO announced today the launch of their first joint AI-powered process orchestration solution. The new offering ...
Uttar Pradesh plans to implement automatic property mutation after registration to simplify ownership updates and reduce ...
Part 0, C04Survey Reference Date: October 25, 2026What You Will Learn in This Article・The flow from receiving a consultation ...
Updated service framework establishes structured project management, standardized Pacific Northwest pricing benchmarks, ...
Agentic AI is moving biopharma from tools that inform decisions to systems that execute them, reshaping discovery, clinical ...
Swarmer, Inc (“Swarmer”) (NASDAQ: SWMR), a drone autonomy platform company that has supported more than 100,000 real-world ...
Phase 3 OASIZ-301 Study of Dazodalibep in Sjögren's Disease Shows Statistically Significant and Clinically Meaningful ...
Single administration of SERP-01 was associated with increases in total serum AAT above the protective threshold with durable correction out to ...
At 960 mg daily, 5.9% of 68 participants had grade 3 treatment-related events; treatment-related events prompted dose ...
An international observational study of 80 advanced cancer patients finds that palliative sedation is typically prompted by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results